PETROSCRAP.COM

Pro-Pharmaceuticals to Receive $489,000 in Federal Grants for Its Galectin-Targeting Cancer and Liver Fibrosis Compounds
NEWTON, Mass.–(BUSINESS WIRE)–Pro-Pharmaceuticals, Inc. (OTC: PRWP), a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today announced it has been notified that it has been awarded approximately $489,000 total in two federal grants under the Qualifying Therapeutic Discovery Project (“QTDP”) Program. The criteria for getting the grants were: Unique …

Read more on Business Wire

This entry was posted on Wednesday, November 3rd, 2010 at 5:35 pm and is filed under Polymer News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.